SCHEMBL3134057

SCHEMBL3134057

NC(=O)CCCCNS(=O)(=O)c1cccc(-c2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
TBXA2R P21731 2/20 0.59
HDAC1 Q13547 2/20 0.55
HDAC2 Q92769 1/20 0.55
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
PKM P14618 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HDAC6 Q9UBN7 1/20 0.53
HDAC3 O15379 1/20 0.51
LARS1 Q9P2J5 1/20 0.49
MMP2 P08253 2/20 0.49
MMP9 P14780 2/20 0.49
ATM Q13315 1/20 0.49
AKR1C3 P42330 1/20 0.47
PFKFB3 Q16875 1/20 0.47
FABP4 P15090 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEP1B Q16820 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3142362 0.87 HDAC1 (0.70) ALDH1A1TBXA2RHDAC1HDAC2KDM4E
SCHEMBL22467259 0.87 ALDH1A1 (0.77) ALDH1A1TBXA2RHDAC1HDAC2KDM4E
SCHEMBL3171207 0.86 ALDH1A1 (0.79) ALDH1A1TBXA2RHDAC1HDAC2KDM4E
SCHEMBL12570967 0.85 ALDH1A1 (0.58) ALDH1A1TBXA2RHDAC1HDAC2KDM4E
SCHEMBL3147274 0.80 ALDH1A1 (0.73) ALDH1A1TBXA2RLMNASMN1; SMN2
SCHEMBL4617581 0.78 ATM (0.55) ALDH1A1TBXA2RHDAC2KDM4ELMNA
SCHEMBL3687106 0.78 ALDH1A1 (0.61) ALDH1A1TBXA2RHDAC1KDM4ELMNA
SCHEMBL2008191 0.77 ALDH1A1 (0.80) ALDH1A1TBXA2RHDAC1HDAC2KDM4E
SCHEMBL13244191 0.77 ALDH1A1 (0.69) ALDH1A1TBXA2RHDAC1LMNAHDAC3
SCHEMBL3383427 0.76 ALDH1A1 (0.97) ALDH1A1TBXA2RHDAC1HDAC2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004339-A1 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists OY JUVANTIA PHARMA LTD. (FI) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004339-A1 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists SSTR4, SSTR1, SSTR3 ALDH1A1 4124/4885TBXA2R 168/4885HDAC1 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.